INTL MEDICATION
GenericsINTL MEDICATION is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Immunology.
INTL MEDICATION's Key Drugs
INTL MEDICATION's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
INTL MEDICATION's Recent FDA Approvals
New NDA/BLA approvals for INTL MEDICATION over the last two years — novel drugs only, excluding generics and label supplements.
INTL MEDICATION's Therapeutic Areas
INTL MEDICATION's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Gastroenterology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
INTL MEDICATION's Top Competitors
INTL MEDICATION's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
INTL MEDICATION Pipeline Snapshot
Active clinical trials for INTL MEDICATION across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1975-08-29
- Latest
- 2025-12-22
- Applications
- 47